about
Hepatotoxicity of halogenated inhalational anestheticsExposure to volatile anaesthetics is not followed by a massive induction of single-strand DNA breaks in operation theatre personnelHalothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.Acute renal dysfunction in liver diseasesRetrospective cohort investigation of perioperative upper respiratory events in children undergoing general anesthesia via a supraglottic airway: A comparison of sevoflurane and desflurane.Desflurane: a clinical update of a third-generation inhaled anaesthetic.Impact of obesity on drug metabolism and elimination in adults and children.Contributions of caspase-8 and -9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons.The effects of N-acetylcysteine on hepatic function during isoflurane anaesthesia for laparoscopic surgery patients.Fulminant hepatic failure after repeated exposure to isoflurane.Effects of propofol versus isoflurane on liver function after open thoracotomy.Isoflurane Is More Deleterious to Developing Brain Than Desflurane: The Role of the Akt/GSK3β Signaling Pathway.Sevoflurane therapy for life-threatening acute severe asthma: a case report.Volatile Anesthetics and Immunity.Intraoperative factors associated with delayed recovery of liver function after hepatectomy: analysis of 1969 living donors.Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients.Evaluation of effects of repeated sevoflurane exposure on rat testicular tissue and reproductive hormones.
P2860
Q28080572-688E53CA-C191-48E5-8918-38E201EAD7CEQ28385238-CB192B57-00E6-4D3A-B052-A7FB377EFF2EQ35507135-937B585E-B7C8-4B51-8192-9F2A7C535270Q36975923-7B1DEA7E-6CA1-4D8A-8977-A9AF842900E7Q37116966-336FE1B4-5685-4C17-B2C6-D25B07099F3EQ37970432-4EE10480-9255-4DE2-8D4B-D7E6F396F528Q37997025-97E80DF2-1730-4144-B0E9-A76503FE4137Q38721677-2610FD37-A943-46F8-953A-DEED77BA73A1Q40109935-A6CE19F8-00BD-4237-ABA6-7D7F95BCEFEBQ41838632-DDA4649F-DC8A-4632-9CCC-1E449A609F08Q42187291-48F00573-99C8-4A8E-A1D4-0E5331F5593EQ42570994-56F41553-C74B-4BE0-A239-F060650F2E53Q44074945-B944CDBD-F26F-425C-849E-BB3461C74783Q47239314-B8F0C479-7FFB-4917-8DF3-8B0CCC03B4D3Q47596131-055EA31B-28A4-4A0B-B3D6-996EA0B9BE60Q47981946-3341A889-6F89-4DE8-9242-DF7F4C8016D6Q48028293-72B36167-9575-4AC3-A9A9-88C4E4407DAC
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Halogenated inhalational anaesthetics.
@ast
Halogenated inhalational anaesthetics.
@en
type
label
Halogenated inhalational anaesthetics.
@ast
Halogenated inhalational anaesthetics.
@en
prefLabel
Halogenated inhalational anaesthetics.
@ast
Halogenated inhalational anaesthetics.
@en
P356
P1476
Halogenated inhalational anaesthetics.
@en
P2093
Florian M Reichle
Peter F Conzen
P356
10.1053/BEAN.2002.0265
P577
2003-03-01T00:00:00Z